RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.550
-0.110 (-4.14%)
At close: Apr 1, 2025, 4:00 PM
2.597
+0.047 (1.83%)
After-hours: Apr 1, 2025, 4:33 PM EDT

RedHill Biopharma Market Cap

RedHill Biopharma has a market cap or net worth of $3.27 million as of April 1, 2025. Its market cap has increased by 92.08% in one year.

Market Cap
3.27M
Enterprise Value
-3.38M
1-Year Change
92.08%
Ranking
Category
Stock Price
$2.55

Market Cap Chart

Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $3.27M, a decrease of -94.45%. That is a compound annual growth rate of -21.05%.

History

DateMarket Cap% Change
Mar 28, 20253.60M-54.43%
Dec 31, 20247.90M68.09%
Dec 29, 20234.70M-47.78%
Dec 30, 20229.00M-92.54%
Dec 31, 2021120.70M-57.65%
Dec 31, 2020285.00M65.51%
Dec 31, 2019172.20M45.81%
Dec 31, 2018118.10M34.66%
Dec 29, 201787.70M-34.06%
Dec 30, 2016133.00M17.49%
Dec 31, 2015113.20M31.93%
Dec 31, 201485.80M37.28%
Dec 31, 201362.50M6.29%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings